Oleg Demidov

Dr. Oleg Demidov

Faculty of Medicine and Pharmacy, Université de Bourgogne Franche-Comté, Dijon, France
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2002 in Nature Genetics
Verified
Journal Article
Closed access
DBDmitry V. Bulavin
Dmitry V. Bulavin
Oleg DemidovOleg Demidov
Oleg Demidov
SSShin'Ichi Saito
Shin'Ichi Saito
PKPaivikki Kauraniemi
Paivikki Kauraniemi
CPCrissy Phillips
Crissy Phillips
EAEttore Appella
Ettore Appella

1 September 2006 in Molecular Cell
Verified
Journal Article
Closed access
SSSathyavageeswaran Shreeram
Sathyavageeswaran Shreeram
Oleg DemidovOleg Demidov
Oleg Demidov
WHWeng Kee Hee
Weng Kee Hee
HYHiroshi Yamaguchi
Hiroshi Yamaguchi
NONobuyuki Onishi
Nobuyuki Onishi
DBDmitry V. Bulavin
Dmitry V. Bulavin

1 December 2012 in Cancer Letters
Verified
Journal Article
Closed access
AGAnastasia R. Goloudina
Anastasia R. Goloudina
Oleg DemidovOleg Demidov
Oleg Demidov
GCGarrido Carmen
Garrido Carmen

1 January 2019 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
ETEugene Tulchinsky
Eugene Tulchinsky
Oleg DemidovOleg Demidov
Oleg Demidov
MKMarina Kriajevska
Marina Kriajevska
NBNickolai A. Barlev
Nickolai A. Barlev
EIEvgeny N. Imyanitov
Evgeny N. Imyanitov

1 February 2002 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
JCJene Choi
Jene Choi
BNBonnie Nannenga
Bonnie Nannenga
Oleg DemidovOleg Demidov
Oleg Demidov
DBDmitry V. Bulavin
Dmitry V. Bulavin
ACAustin Cooney
Austin Cooney
LDLawrence A. Donehower
Lawrence A. Donehower
The Wip1 gene is a serine/threonine phosphatase that is induced in a p53-dependent manner by DNA-damaging agents. We show here that Wip1 message is expressed in moderate levels in all organs, but is present at very high levels in the testes, particularly in the postmeiotic round spermatid compartment of the seminiferous tubules. We have confirmed that Wip1 mRNA is induced by ionizing radiation in mouse tissues in a p53-dependent manner. To further determine the normal biological function of Wip1 in mammalian organisms, we have generated Wip1-deficient mice. Wip1 null mice are viable but show a variety of postnatal abnormalities, including variable male runting, male reproductive organ atrophy, reduced male fertility, and reduced male longevity. Mice lacking Wip1 show increased susceptibility to pathogens and diminished T- and B-cell function. Fibroblasts derived from Wip1 null embryos have decreased proliferation rates and appear to be compromised in entering mitosis. The data are consistent with an important role for Wip1 in spermatogenesis, lymphoid cell function, and cell cycle regulation.

13 January 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
ARAnne-Laure Rérole
Anne-Laure Rérole
JGJessica Gobbo
Jessica Gobbo
ATAurelie De Thonel
Aurelie De Thonel
ESElise Schmitt
Elise Schmitt
JBJean Paul Pais de Barros
Jean Paul Pais de Barros
GCGarrido Carmen
Garrido Carmen
The inhibition of heat shock protein 70 (HSP70) is an emerging strategy in cancer therapy. Unfortunately, no specific inhibitors are clinically available. By yeast two-hybrid screening, we have identified multiple peptide aptamers that bind HSP70. When expressed in human tumor cells, two among these peptide aptamers—A8 and A17—which bind to the peptide-binding and the ATP-binding domains of HSP70, respectively, specifically inhibited the chaperone activity, thereby increasing the cells' sensitivity to apoptosis induced by anticancer drugs. The 13-amino acid peptide from the variable region of A17 (called P17) retained the ability to specifically inhibit HSP70 and induced the regression of subcutaneous tumors in vivo after local or systemic injection. This antitumor effect was associated with an important recruitment of macrophages and T lymphocytes into the tumor bed. Altogether, these data indicate that peptide aptamers or peptides that target HSP70 may be considered as novel lead compounds for cancer therapy. Cancer Res; 71(2); 484–95. ©2011 AACR.